pubmed.ncbi.nlm.nih.gov

Somatotropic signaling: trade-offs between growth, reproductive development, and longevity - PubMed

Review

Somatotropic signaling: trade-offs between growth, reproductive development, and longevity

Andrzej Bartke et al. Physiol Rev. 2013 Apr.

Abstract

Growth hormone (GH) is a key determinant of postnatal growth and plays an important role in the control of metabolism and body composition. Surprisingly, deficiency in GH signaling delays aging and remarkably extends longevity in laboratory mice. In GH-deficient and GH-resistant animals, the "healthspan" is also extended with delays in cognitive decline and in the onset of age-related disease. The role of hormones homologous to insulin-like growth factor (IGF, an important mediator of GH actions) in the control of aging and lifespan is evolutionarily conserved from worms to mammals with some homologies extending to unicellular yeast. The combination of reduced GH, IGF-I, and insulin signaling likely contributes to extended longevity in GH or GH receptor-deficient organisms. Diminutive body size and reduced fecundity of GH-deficient and GH-resistant mice can be viewed as trade-offs for extended longevity. Mechanisms responsible for delayed aging of GH-related mutants include enhanced stress resistance and xenobiotic metabolism, reduced inflammation, improved insulin signaling, and various metabolic adjustments. Pathological excess of GH reduces life expectancy in men as well as in mice, and GH resistance or deficiency provides protection from major age-related diseases, including diabetes and cancer, in both species. However, there is yet no evidence of increased longevity in GH-resistant or GH-deficient humans, possibly due to non-age-related deaths. Results obtained in GH-related mutant mice provide striking examples of mutations of a single gene delaying aging, reducing age-related disease, and extending lifespan in a mammal and providing novel experimental systems for the study of mechanisms of aging.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.

Age-related decline in circulating levels of human growth hormone (GH) and insulin-like growth factor I (IGF-I).[From Corpas et al. (69) and Zadik et al. (335), with permission from The Endocrine Society.]

Figure 2.
Figure 2.

Schematic representation of key mechanisms of growth hormone (GH) signaling. GH binds to two transmembrane GH receptors and alters expression of numerous genes via activation of STAT and ERK; details and references are in the text.

Figure 3.
Figure 3.

The somatotropic axis. This diagram contrasts endocrine, primarily hepatic IGF-I that acts as a mediator of GH actions with partially or completely GH-independent IGF-1 produced by other organs that can act locally in paracrine or autocrine fashion.

Figure 4.
Figure 4.

Key mechanisms linking GH signaling with adiposity, insulin resistance, and cardiovascular disease (CVD). Details and additional mechanisms are in the text.

Figure 5.
Figure 5.

Mechanisms believed to be involved in linking GH signaling with healthspan and lifespan. Details and references are in the text and in TABLE 2.

Similar articles

  • Somatotropic Axis, Pace of Life and Aging.

    Bartke A. Bartke A. Front Endocrinol (Lausanne). 2022 Jul 14;13:916139. doi: 10.3389/fendo.2022.916139. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909509 Free PMC article. Review.

  • Growth hormone and aging.

    Bartke A. Bartke A. Rev Endocr Metab Disord. 2021 Mar;22(1):71-80. doi: 10.1007/s11154-020-09593-2. Epub 2020 Oct 1. Rev Endocr Metab Disord. 2021. PMID: 33001358 Review.

  • Life extension in the dwarf mouse.

    Bartke A, Brown-Borg H. Bartke A, et al. Curr Top Dev Biol. 2004;63:189-225. doi: 10.1016/S0070-2153(04)63006-7. Curr Top Dev Biol. 2004. PMID: 15536017 Review.

  • Links between growth hormone and aging.

    Bartke A, Westbrook R, Sun L, Ratajczak M. Bartke A, et al. Endokrynol Pol. 2013;64(1):46-52. Endokrynol Pol. 2013. PMID: 23450447 Free PMC article. Review.

  • GH and ageing: Pitfalls and new insights.

    Bartke A, Darcy J. Bartke A, et al. Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):113-125. doi: 10.1016/j.beem.2017.02.005. Epub 2017 Feb 24. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 28477727 Free PMC article. Review.

Cited by

References

    1. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scientific World J 6: 53–80, 2006 - PMC - PubMed
    1. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531–1537, 2002 - PubMed
    1. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor I/insulin signaling and caloric restriction. Endocrinology 146: 851–860, 2005 - PubMed
    1. Al-Regaiey KA, Masternak MM, Bonkowski MS, Panici JA, Kopchick JJ, Bartke A. Effects of caloric restriction and growth hormone resistance on insulin-related intermediates in the skeletal muscle. J Gerontol A Biol Sci Med Sci 62: 18–26, 2007 - PubMed
    1. Alcantara MR, Salvatori R, Alcantara PR, Nobrega LM, Campos VS, Oliveira EC, Oliveira MH, Souza AH, Aguiar-Oliveira MH. Thyroid morphology and function in adults with untreated isolated growth hormone deficiency. J Clin Endocrinol Metab 91: 860–864, 2006 - PubMed

Publication types

MeSH terms

Substances